Ranked by rounds participated in, from announcements in Jul 19, 2026 – Oct 16, 2026. Lead counts include only confirmed lead roles.
New companies 42 · Follow-on 1
Stages: Seed 17, Series A 10, Pre-seed 5, Series B 4, Series C+ 4, Undisclosed 3
Nous Research $90M Series BSanté $15M Series AVitalize $31M Series ANew companies 19 · Follow-on 1
Stages: Series B 7, Seed 6, Undisclosed 4, Series C+ 2, Series A 1
Arena $200M Series BVinci $250M Series BVarda $251M Series DNew companies 17 · Follow-on 1
Stages: Series B 9, Series A 3, Series C+ 3, Undisclosed 2, Seed 1
Stuut $52.5M Series BHestus, Inc. $7.4M SeedQuartermaster $140M Series B equity + debt facilityNew companies 18 · Follow-on 0
Stages: Series C+ 7, Series A 3, Series B 3, Seed 2, Undisclosed 2, Pre-seed 1
Devoted Health $555M Series GJeeves $110M Series C-1EliseAI $350M Growth financingNew companies 15 · Follow-on 2
Stages: Series C+ 8, Series B 7, Seed 1, Series A 1
TypeSafe AI $870M Series AArena $200M Series BVesta $30M Series BNew companies 16 · Follow-on 1
Stages: Series A 5, Seed 4, Series C+ 3, Undisclosed 3, Series B 2
Savvy Wealth $100M Series CMona $3.5M Oversubscribed roundFootprint $25M Series BNew companies 13 · Follow-on 2
Stages: Series C+ 8, Undisclosed 3, Series B 2, Seed 1, Series A 1
TypeSafe AI $870M Series AMecka $60M Series BAugmeta $3M SeedNew companies 14 · Follow-on 1
Stages: Seed 8, Series A 3, Series B 2, Series C+ 2
General Medicine $120M Series BCorridor $25M SeedFootprint $25M Series BNew companies 13 · Follow-on 2
Stages: Series C+ 4, Undisclosed 4, Seed 3, Series A 2, Pre-seed 1, Series B 1
Minerva Humanoids Undisclosed Pre-SeedMelius $20M Series AVarda $251M Series DNew companies 13 · Follow-on 2
Stages: Series B 4, Series A 3, Seed 2, Series C+ 2, Undisclosed 2, Growth 1, Pre-seed 1
Miter $40M Series BEliseAI $350M Growth financingStarSling Undisclosed Pre-SeedNew companies 12 · Follow-on 1
Stages: Series A 6, Series C+ 4, Series B 2, Pre-seed 1
HiringCafe $6.8M Pre-seedRune $40M Series APiston $15M Series ANew companies 11 · Follow-on 1
Stages: Series C+ 8, Series B 2, Growth 1, Undisclosed 1
General Intuition $220M UndisclosedCrusoe >$3.9B Series FImpulse Space $308M Series D extensionNew companies 11 · Follow-on 0
Stages: Series B 5, Series A 2, Series C+ 2, Seed 1, Undisclosed 1
General Medicine $120M Series BThatch $108M New fundingCircle Pharma, Inc. $92.5M Series ENew companies 5 · Follow-on 5
Stages: Series B 7, Pre-seed 1, Series A 1, Series C+ 1
Nous Research $90M Series BArmadin $255.5M Series BGimlet Labs $300M Series BNew companies 6 · Follow-on 4
Stages: Series A 3, Series B 3, Series C+ 2, Seed 1, Undisclosed 1
Armadin $255.5M Series BEma $77M Series BCognition >$2B Series ENew companies 10 · Follow-on 0
Stages: Growth 3, Series A 2, Series B 2, Seed 1, Series C+ 1, Undisclosed 1
Miter $40M Series BFeldera $15.4M Series APhigenics Undisclosed InvestmentNew companies 8 · Follow-on 2
Stages: Series C+ 5, Growth 2, Series A 1, Series B 1, Undisclosed 1
General Intuition $220M UndisclosedCrusoe >$3.9B Series FPositron AI $875M Series CNew companies 10 · Follow-on 0
Stages: Seed 5, Series C+ 2, Pre-seed 1, Series A 1, Undisclosed 1
Ferry Health $9M SeedTemporal $550M Series ESystem $20M FundingNew companies 8 · Follow-on 1
Stages: Series A 3, Series C+ 3, Series B 2, Undisclosed 1
Arena $200M Series BAnde Undisclosed Series ASnorkel AI $350M Series ENew companies 7 · Follow-on 2
Stages: Series C+ 4, Series B 2, Seed 1, Series A 1, Undisclosed 1
Multiply Labs $75M Series BVarda $251M Series DCrusoe >$3.9B Series FNew companies 7 · Follow-on 2
Stages: Seed 3, Series C+ 3, Series B 2, Growth 1
Multiply Labs $75M Series BVarda $251M Series DImpulse Space $308M Series D extensionNew companies 9 · Follow-on 0
Stages: Series B 4, Undisclosed 3, Series A 1, Series C+ 1
Mecka $60M Series BNous Research $90M Series BCrusoe >$3.9B Series FNew companies 8 · Follow-on 1
Stages: Seed 3, Series B 3, Series C+ 2, Undisclosed 1
Savvy Wealth $100M Series CAugmeta $3M SeedFootprint $25M Series BNew companies 8 · Follow-on 1
Stages: Series B 3, Series C+ 3, Series A 2, Growth 1
Armadin $255.5M Series BBigHat Biosciences $75M Series CVals AI $40M Series ANew companies 8 · Follow-on 1
Stages: Series C+ 4, Seed 2, Series B 2, Series A 1
Armadin $255.5M Series BAnde Undisclosed Series ACorridor $25M SeedNew companies 9 · Follow-on 0
Stages: Series A 4, Series C+ 3, Seed 1, Series B 1
Jeeves $110M Series C-1Firecrawl $75M Series BRaindrop Undisclosed Series ANew companies 7 · Follow-on 1
Stages: Series C+ 4, Series B 2, Seed 1, Undisclosed 1
Arena $200M Series BNumeral $100M Series CCrusoe >$3.9B Series FNew companies 7 · Follow-on 1
Stages: Series C+ 3, Series B 2, Undisclosed 2, Seed 1
Vinci $250M Series BEfficient Computer $100M Additional fundingNoetive $41M SeedNew companies 8 · Follow-on 0
Stages: Series A 4, Series C+ 2, Seed 1, Series B 1
Vitalize $31M Series AHalluminate $30M Series ALatitude $35M Series ANew companies 8 · Follow-on 0
Stages: Series A 3, Series C+ 3, Series B 1, Undisclosed 1
Circle Pharma, Inc. $92.5M Series ESolstice Oncology $225M Series ASuperluminal Medicines $60M Series B“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.